These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21320390)

  • 21. Pharmacotherapy for borderline patients: business as usual or by default?
    Ingenhoven T
    J Clin Psychiatry; 2015 Apr; 76(4):e522-3. PubMed ID: 25919847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrating psychotherapy and pharmacotherapy.
    Hyland JM
    Bull Menninger Clin; 1991; 55(2):205-15. PubMed ID: 1675140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical trials of treatment for personality disorders.
    Paris J
    Psychiatr Clin North Am; 2008 Sep; 31(3):517-26, viii. PubMed ID: 18638650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toward an integrative model of the spectrum of mood, behavioral and personality disorders based on fear and anger traits: II. Implications for neurobiology, genetics and psychopharmacological treatment.
    Lara DR; Akiskal HS
    J Affect Disord; 2006 Aug; 94(1-3):89-103. PubMed ID: 16712943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medication prescribed to people with personality disorder: the influence of patient factors and treatment setting.
    Crawford MJ; Kakad S; Rendel C; Mansour NA; Crugel M; Liu KW; Paton C; Barnes TR
    Acta Psychiatr Scand; 2011 Nov; 124(5):396-402. PubMed ID: 21707555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Personality disorders in a nonclinical sample of adolescents].
    Chabrol H; Chouicha K; Montovany A; Callahan S; Duconge E; Sztulman H
    Encephale; 2002; 28(6 Pt 1):520-4. PubMed ID: 12506264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacotherapy in personality disorders.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2007 Jun; 45(6):15-9. PubMed ID: 17601155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comorbidity of axis I and axis II disorders.
    Oldham JM; Skodol AE; Kellman HD; Hyler SE; Doidge N; Rosnick L; Gallaher PE
    Am J Psychiatry; 1995 Apr; 152(4):571-8. PubMed ID: 7694906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Perspectives of psychiatric pharmacotherapy].
    Hippius H
    Wien Klin Wochenschr Suppl; 1986; 170():7-10. PubMed ID: 3468686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychotropic medication use pre and post-diagnosis of cluster B personality disorder: a Quebec's health services register cohort.
    Lunghi C; Cailhol L; Massamba V; Laouan Sidi EA; Sirois C; Rahme E; Rochette L; Renaud S; Villeneuve E; Koch M; Biskin R; Martineau C; Vincent P; David P; Lesage A
    Front Psychiatry; 2023; 14():1243511. PubMed ID: 38076683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment outcome of personality disorders.
    Sanislow CA; McGlashan TH
    Can J Psychiatry; 1998 Apr; 43(3):237-50. PubMed ID: 9561312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Psychopathy and associated personality disorders: searching for a particular effect of the borderline personality disorder?].
    Nioche A; Pham TH; Ducro C; de Beaurepaire C; Chudzik L; Courtois R; Réveillère C
    Encephale; 2010 Jun; 36(3):253-9. PubMed ID: 20620268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychopharmacological interventions in autism spectrum disorder.
    Politte LC; Henry CA; McDougle CJ
    Harv Rev Psychiatry; 2014; 22(2):76-92. PubMed ID: 24614763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Psychopharmacological treatment: patients' knowledge about their medication].
    Zanieri G; Buizza C; Ravelli L; Bignotti S; Porteri C; Pioli R; Saltini A
    Recenti Prog Med; 2003 Sep; 94(9):387-90. PubMed ID: 12942800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of outpatients with borderline personality disorder.
    Sweeney DR
    J Clin Psychiatry; 1987 Aug; 48 Suppl():32-7. PubMed ID: 2886495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment and management of dangerous and severe personality disorders.
    Völlm B
    Curr Opin Psychiatry; 2009 Sep; 22(5):501-6. PubMed ID: 19424066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Personality and personality disorders in the elderly: diagnostic, course and management].
    Amad A; Geoffroy PA; Vaiva G; Thomas P
    Encephale; 2013 Oct; 39(5):374-82. PubMed ID: 23095604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The psychopharmacologic treatment of personality disorders.
    Klar H; Siever LJ
    Psychiatr Clin North Am; 1984 Dec; 7(4):791-801. PubMed ID: 6151648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacotherapy of personality disorders in German speaking countries: state and changes in the last decade.
    Heinze M; Andreae D; Grohmann R
    Pharmacopsychiatry; 2005 Sep; 38(5):201-5. PubMed ID: 16189746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The neurobiology of personality disorders: implications for psychoanalysis.
    Siever LJ; Weinstein LN
    J Am Psychoanal Assoc; 2009 Apr; 57(2):361-98. PubMed ID: 19516057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.